Share on Pinterest Research on GLP-1 drugs and eye health has been inconsistent, but experts say the risk of serious eye disease is generally low. Getty Images/Hiraman Studies have linked GLP-1 ...
Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...
Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of ...
Artificial intelligence is radically changing how healthcare providers tackle vision loss, with tools that can be used from diagnosis to treatment and even follow-up care. One such example is Visilant ...
A small percentage of patients on injectable weight loss drugs such as Ozempic and Wegovy experienced permanent vision loss, according to a new study. The report, published Thursday in the medical ...
Add Yahoo as a preferred source to see more of our stories on Google. With more people turning to popular weight-loss medications, questions about potential side effects are increasing — and some ...
The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues. Scientists have been closely studying this association as more people turn to these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results